HR4084-119

In Committee

Access to Birth Control Act

119th Congress Introduced Jun 23, 2025

Summary

What This Bill Does

The Access to Birth Control Act creates federal duties for pharmacies that receive FDA-approved, cleared, or authorized contraception or contraception-related medication in interstate commerce. If a requested product is in stock, the pharmacy must provide it without delay. If it is not in stock but the pharmacy normally stocks it, the pharmacy must immediately tell the customer and, without delay, either locate and refer or transfer the prescription to a pharmacy chosen by the customer or the closest confirmed pharmacy, or order it under expedited procedures and notify the customer when it arrives. Pharmacies also must avoid environments where customers are intimidated, threatened, or harassed, and employees may not interfere with or obstruct contraception services or intentionally misrepresent availability.

Who Benefits and How

Contraception patients benefit because in-stock contraceptives and related medications must be provided without delay. Prescription-transfer patients benefit from required referral, transfer, or expedited ordering options when the pharmacy is out of stock. Women facing geographic, cost, language, immigration-status, discrimination, or stigma barriers benefit from a federal access standard at pharmacies. Reproductive health advocates benefit from enforceable pharmacy duties tied to contraception access.

Who Bears the Burden and How

Pharmacy providers must maintain compliance procedures for in-stock provision, out-of-stock notices, transfers, referrals, expedited ordering, and customer notifications. Pharmacy employees must avoid interference, obstruction, intimidation, harassment, and intentional misrepresentation of availability. Pharmacy chain employers must train staff and monitor store environments for contraception-access compliance. Objecting pharmacy workers may face workplace constraints when refusal or obstruction would delay patient access.

Key Provisions

  • Requires pharmacies to provide in-stock contraception and related medication without delay.
  • Requires immediate notice plus referral, prescription transfer, or expedited ordering when requested products are out of stock.
  • Prohibits intimidation, threats, harassment, interference, obstruction, and intentional misrepresentation in contraception service delivery.
  • Applies to pharmacies receiving FDA-approved, cleared, or authorized contraception products in interstate commerce.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Requires pharmacies receiving FDA-approved, cleared, or authorized contraceptive products in interstate commerce to provide in-stock contraception without delay, arrange transfer or ordering when out of stock, prevent intimidation or obstruction, and follow federal contraception access duties.

Key Policy Areas

Reproductive Health, Pharmacy, Public Health

Primary Purpose

Requires pharmacies receiving FDA-approved, cleared, or authorized contraceptive products in interstate commerce to provide in-stock contraception without delay, arrange transfer or ordering when out of stock, prevent intimidation or obstruction, and follow federal contraception access duties.

Policy Domains

Reproductive Health Pharmacy Public Health

Resolution provisions

Identified Gains
  • Contraception patients
  • Prescription-transfer patients
  • Women patients facing access barriers
  • Reproductive health advocates
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Contraception patients: , ,
Reproductive health advocates: , ,
Prescription-transfer patients: , ,
Women patients facing access barriers: , ,
Identified Costs
  • Pharmacy providers
  • Pharmacy employees
  • Pharmacy chain employers
  • Objecting pharmacy workers
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Pharmacy employees: , ,
Pharmacy providers: , ,
Pharmacy chain employers: , ,
Objecting pharmacy workers: , ,

Legislative Progress

In Committee
Introduced Committee Passed
Jun 23, 2025

Ms. Kelly of Illinois (for herself, Mr. Foster, Ms. Norton, …

Jun 23, 2025

Referred to the House Committee on Energy and Commerce.

Jun 23, 2025

Introduced in House

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Healthcare
15 mentions across 3 clauses
-6 negative ?9 uncertain

Contraception patients, Objecting pharmacy workers, Pharmacy employees

3/4
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Reproductive Health Pharmacy Public Health

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology